Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis

Journal of Dermatology

Volumn 38, Issue 2, 2011, Pages 131-139

  Moroi, Miki ^a   Uchi, Sahori ^a   Nakamura, Kenjiro ^a   Sato, Saori ^b   Shimizu, Nobuyuki ^c   Fujii, Mikio ^d   Kumagai, Takehisa ^d   Saito, Mariko ^d   Uchiyama, Kimiko ^d   Watanabe, Toshiyuki ^d   Yamaguchi, Hideyo ^e   Yamamoto, Tetsuro ^e   Takeuchi, Satoshi ^f   Furue, Masutaka ^f  

^a Tenjin Sogo Clinic   (Japan)

^b Higashi Hie Clinic of Dermatology   (Japan)

^c Shimizu Hifuka Clinic   (Japan)

^d Kameda Seika Co   (Japan)

^e TOTAL   (France)

^f KYUSHU UNIVERSITY   (Japan)

Author keywords

atopic dermatitis; complementary therapy; heat killed probiotic bacteria; Lactobacillus paracasei; randomized controlled trial

Indexed keywords

CORTICOSTEROID; PLACEBO; PROBIOTIC AGENT; TACROLIMUS;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; DIET THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LACTOBACILLUS PARACASEI; MALE; NAUSEA; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADRENAL CORTEX HORMONES; ADULT; AGED; COMPLEMENTARY THERAPIES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HOT TEMPERATURE; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 79251551091     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00939.x     Document Type: Article

References (31)

1. Saeki H, Furue M, Furukawa F, et al. Guidelines for management of atopic dermatitis. J Dermatol 2009; 36: 563-577.
2. Galli E, Cicconi R, Rossi P, Casati A, Brunetti E, Mancino G,. Atopic dermatitis: molecular mechanisms, clinical aspects and new therapeutical approaches. Curr Mol Med 2003; 3: 127-138.
3. Takeuchi M, Ueda H,. Increase of adult atopic dermatitis (AD) in recent Japan. Environ Dermatol 2000; 7: 133-136.
4. Saeki H, Tsunemi Y, Fujita H, et al. Prevalence of atopic dermatitis determined by clinical examination in Japanese adults. J Dermatol 2006; 33: 817-819.
5. Ellis C, Luger T, Abeck D, et al. International consensus conference on atopic dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003; 148 (Suppl 63): 3-10.
6. Charman CR, Morris AD, Williams HC,. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931-936.
7. Ouwehand AC, Salminen S, Isolauri E,. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002; 82: 279-289.
8. Kalliomäki MA, Isolauri E,. Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am 2004; 24: 739-752.
9. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80: S147-S171.
10. Sanders ME,. Probiotics: considerations for human health. Nutr Rev 2003; 61: 91-99.
11. Majamaa H, Isolauri E,. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99: 179-185.
12. Pessi T, Sütas Y, Hurme M, Isolauri E,. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000; 30: 1804-1808.
13. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-395.
14. Weston S, Halbert A, Richmond P, Prescott SL,. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90: 892-897.
15. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60: 494-500.
16. Michail SK, Stolfi A, Johnson T, Onady GM,. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101: 508-516.
17. Matsumoto M, Aranami A, Ishige A, Watanabe K, Benno Y,. LKM 512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clin Exp Allergy 2007; 37: 358-370.
18. Roessler (nee Klein) A, Friedrich U, Vogelsang H, et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 2008; 38: 93-102.
19. Fujiwara D, Inoue S, Wakabayashi H, Fujii T,. The anti-allergic effects of lactic acid bacteria are strain-dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 2004; 135: 205-215.
20. Shida K, Takahashi R, Iwadate E, et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002; 32: 563-570.
21. Murosaki S, Yamamoto Y, Ito K, et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol 1998; 102: 57-64.
22. Sawada J, Morita H, Tanaka A, Salminen S, He F, Matsuda H,. Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clin Exp Allergy 2007; 37: 296-303.
23. Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005; 88: 527-533.
24. Kobayashi H, Ishii M, Takeuchi S, et al. Efficacy and safety of a traditional herbal medicine, Hochu-ekki-to in the long-term management of Kikyo (Delicate constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Alternat Med Published online: 31 January, 2008; doi:.
25. Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M,. Translation of Skindex 16 into Japanese, a disease-specific instrument to measure quality of life in patients with skin diseases. Jpn J Clin Dermatol 2002; 56: 301-303.
26. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S,. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30: 1604-1610.
27. Wagner RD, Pierson C, Warner T, Dohnalek M, Hilty M, Balish E,. Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice. J Food Prot 2000; 63: 638-644.
28. + T cell-mediated skin inflammation. Eur J Immunol 2004; 34: 2520-2528.
29. Ukabam SO, Mann RJ, Cooper BT,. Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol 1984; 110: 649-652.
30. Majamaa H, Isolauri E,. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol 1996; 97: 985-990.
31. Wold AE,. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 1998; 53 (Suppl 46): 20-25.